Safety, Tolerability and Pharmacokinetics of Single Dose Intravenous Moxifloxacin in Pediatric Patients

NCT01049022 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections

Interventions

DRUG: Moxifloxacin (Avelox, BAY12-8039)
DRUG: Moxifloxacin (Avelox, BAY12-8039)
DRUG: Moxifloxacin (Avelox, BAY12-8039)

Sponsor

Bayer